Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases.
暂无分享,去创建一个
Marco Pradella | Nicola Bizzaro | Renato Tozzoli | Danila Bassetti | Elio Tonutti | Danilo Villalta | Paolo Rizzotti | N. Bizzaro | P. Rizzotti | E. Tonutti | D. Villalta | R. Tozzoli | Fabio Manoni | Anna Piazza | A. Piazza | F. Manoni | D. Bassetti | M. Pradella
[1] R. Nakamura,et al. Importance of detection of ss‐a/ro autoantibody in screening immunofluorescence tests for autoantibodies to nuclear antigens , 1991, Journal of clinical laboratory analysis.
[2] A. Russell,et al. Relative value of commercial kits for ANA testing. , 2003, Clinical and experimental rheumatology.
[3] A Kavanaugh,et al. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. , 2000, Archives of pathology & laboratory medicine.
[4] T. Mimori. Autoantibodies in connective tissue diseases: clinical significance and analysis of target autoantigens. , 1999, Internal medicine.
[5] S. Platzgummer,et al. Accuracy of semiquantitative immunoenzymatic methods in quantitation of anti-topoisomerase I (Scl-70) antibodies , 2005, Clinical Rheumatology.
[6] S. Adelstein,et al. Autoantibodies to Extractable Nuclear Antigens: Making Detection and Interpretation More Meaningful , 2002, Clinical and Vaccine Immunology.
[7] P. Brown,et al. Autoantigen microarrays for multiplex characterization of autoantibody responses , 2002, Nature Medicine.
[8] W. Egner. The use of laboratory tests in the diagnosis of SLE , 2000, Journal of clinical pathology.
[9] S. Lapointe,et al. Sera from patients with autoimmune disease recognize conformational determinants on the 60-kd Ro/SS-A protein. , 1991, Arthritis and rheumatism.
[10] M M HARGRAVES,et al. Presentation of two bone marrow elements; the tart cell and the L.E. cell. , 1948, Proceedings of the staff meetings. Mayo Clinic.
[11] A. Wiik,et al. Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. , 2004, Clinical and experimental rheumatology.
[12] D. Isenberg,et al. Clinical laboratory assays for measuring anti-dsDNA antibodies. Where are we now? , 2002, Lupus.
[13] M. Zweig,et al. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.
[14] B. Mazières,et al. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. , 1996, The Journal of rheumatology.
[15] R. Bogusky,et al. An enzyme immunoassay screening test for the detection of total antinuclear antibodies , 1991, Journal of clinical laboratory analysis.
[16] J. Koziol,et al. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories. , 2003, The Journal of rheumatology.
[17] V. Aidinis,et al. Detection of anti-Ro(SSA) antibodies in autoimmune diseases: comparison of five methods. , 1993, British journal of rheumatology.
[18] N. Bizzaro,et al. Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a collaborative study with the biomedical industry. , 1998, Journal of immunological methods.
[19] S. Kondo,et al. Detection of antinuclear antibodies by use of an enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: comparison with immunofluorescence assay in 307 patients. , 2001, Clinical chemistry.
[20] J. Koziol,et al. Range of antinuclear antibodies in "healthy" individuals. , 1997, Arthritis and rheumatism.
[21] E. Tan,et al. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. , 1989, Advances in immunology.
[22] M. Baldwin,et al. Setting the scene. , 2013, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[23] I. Peene,et al. Sensitivity of the HEp-2000 Substrate for the Detection of Anti-SSA/Ro60 Antibodies , 2000, Clinical Rheumatology.
[24] O. Rekvig,et al. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity , 2004, Annals of the rheumatic diseases.
[25] R. Maini,et al. Manual of Biological Markers of Disease , 1996, Springer Netherlands.
[26] T. Sato,et al. Classification criteria for polymyositis and dermatomyositis. , 1995, The Journal of rheumatology.
[27] I. Kushner,et al. An immunofluorescent method using Crithidia luciliae to detect antibodies to double-stranded DNA. , 1977, Arthritis and rheumatism.
[28] N. Bizzaro,et al. Sensitivity and Specificity of Immunological Methods for the Detection of Anti-Topoisomerase I (Scl70) Autoantibodies: Results of a Multicenter Study , 2000 .
[29] Richard E. Watts,et al. Autoimmune Rheumatic Disease , 1999 .
[30] R. Moore. Evidence-Based Clinical Biochemistry , 1997, Annals of clinical biochemistry.
[31] Evaluation of a new automated enzyme fluoroimmunoassay using recombinant plasmid dsDNA for the detection of anti‐dsDNA antibodies in SLE , 2002, Journal of clinical laboratory analysis.
[32] P. Limburg,et al. Anti-double stranded DNA antibodies in systemic lupus erythematosus: detection and clinical relevance of IgM-class antibodies. , 1996, Scandinavian journal of rheumatology.
[33] S J Gange,et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. , 1997, Clinical immunology and immunopathology.
[34] P. Utz. Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus , 2004, Lupus.
[35] T. Feltkamp,et al. Standardisation of the quantitative determination of antinuclear antibodies (ANAs) with a homogeneous pattern. , 1988, Annals of the rheumatic diseases.
[36] G. Jacob,et al. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods. , 1998, Archives of pathology & laboratory medicine.
[37] R. H. Scofield,et al. SS-A (Ro) Autoantibodies , 1996 .
[38] R. Humbel,et al. Detection of antinuclear antibodies by immunofluorescence , 1996 .
[39] Charles Pj,et al. The Consensus Workshops for the Detection of Autoantibodies to Intracellular Antigens in Rheumatic Diseases: 1989-1992. , 1992 .
[40] M. Reichlin,et al. Serological findings in patients with "ANA-negative" systemic lupus erythematosus. , 1981, Medicine.
[41] D. Sackett,et al. Evidence based medicine: what it is and what it isn't , 1996, BMJ.
[42] R. Sinico,et al. The use of laboratory tests in diagnosis and monitoring of systemic lupus erythematosus. , 2002, Journal of nephrology.
[43] R. Shmerling,et al. Antinuclear Antibody Testing: A Study of Clinical Utility , 1996 .
[44] L. Aarden,et al. Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. , 1979, Arthritis and rheumatism.
[45] E. Tan,et al. Autoantibodies in the diagnosis of systemic rheumatic diseases. , 1995, Seminars in arthritis and rheumatism.
[46] E. Tan,et al. Standards of care: the value and importance of standardization. , 1997, Arthritis and rheumatism.
[47] P. Limburg,et al. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. , 1990, Arthritis and rheumatism.
[48] J. Jarvis,et al. Clinical utility of antinuclear antibody tests in children , 2004, BMC pediatrics.
[49] M. Reichlin,et al. Heterogeneity of the Ro/SSA antigen and autoanti‐Ro/SSA response: evidence of the four antigenically distinct forms , 1990, Clinical and experimental immunology.
[50] J. Buyon,et al. The SS-A/Ro antigen , 1996 .
[51] Daniel H Solomon,et al. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. , 2002, Arthritis and rheumatism.
[52] D. Stott,et al. Immunoblotting and dot blotting , 1989, Journal of Immunological Methods.
[53] F J López-Longo,et al. Simultaneous identification of various antinuclear antibodies using an automated multiparameter line immunoassay system , 2003, Lupus.
[54] A. Wiik,et al. The use and abuse of commercial kits used to detect autoantibodies , 2003, Arthritis research & therapy.
[55] M. Fritzler,et al. Detection of autoantibodies to ss‐a/ro by indirect immunofluorescence using a transfected and overexpressed human 60 kd ro autoantigen in hep‐2 cells , 1995, Journal of clinical laboratory analysis.
[56] T. Jaskowski,et al. Screening for antinuclear antibodies by enzyme immunoassay. , 1996, American journal of clinical pathology.
[57] J. Buyon,et al. Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach. , 2003, Seminars in arthritis and rheumatism.
[58] J. Koziol,et al. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. , 1999, Arthritis and rheumatism.
[59] M. Fritzler,et al. Antinuclear, anticytoplasmic, and anti-Sjogren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors. , 1985, Clinical immunology and immunopathology.
[60] E. Mozes,et al. Detection of antigens in immune complexes by a dot blot assay. , 1995, Journal of immunological methods.
[61] X. Bossuyt. Evaluation of Two Automated Enzyme Immunoassays for Detection of Antinuclear Antibodies , 2000, Clinical chemistry and laboratory medicine.
[62] D. Estes,et al. Antinuclear antibodies. , 1972, Pathobiology annual.
[63] R. Tubbs,et al. Current concepts and advances in clinical laboratory testing for autoimmune diseases. , 1997, Critical reviews in clinical laboratory sciences.
[64] Nicola Bizzaro,et al. Diagnostic Accuracy of Elisa Methods as an Alternative Screening Test to Indirect Immunofluorescence for the Detection of Antinuclear Antibodies. Evaluation of Five Commercial Kits , 2004, Autoimmunity.
[65] Insoo Kang,et al. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies , 2004, Clinical Rheumatology.
[66] Antonella Afeltra,et al. Screening of antinuclear antibodies: comparison between enzyme immunoassay based on nuclear homogenates, purified or recombinant antigens and immunofluorescence assay , 2004, Clinical chemistry and laboratory medicine.
[67] P. Solís,et al. [Diagnosis of autoimmune diseases in hematology]. , 1985, Anales espanoles de pediatria.
[68] D. Stites,et al. Comparison of antinuclear antibody testing methods: immunofluorescence assay versus enzyme immunoassay , 1997, Clinical and diagnostic laboratory immunology.
[69] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[70] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[71] W Emlen,et al. Clinical significance of antinuclear antibodies: comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays. , 1997, Arthritis and rheumatism.
[72] D. Alarcón-Segovia,et al. Reference reagents for antinuclear antibodies , 1988 .
[73] H. Peeters. Protides of the Biological Fluids , 1958 .
[74] I. Peene,et al. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. , 2002, Clinical chemistry.
[75] Y. Takasaki,et al. Clinical significance of autoantibodies to PCNA , 1996 .
[76] Harry R. Hill,et al. Evaluation of Multiplexed Fluorescent Microsphere Immunoassay for Detection of Autoantibodies to Nuclear Antigens , 2004, Clinical Diagnostic Laboratory Immunology.
[77] E. Bonifacio,et al. Use of a standard curve improves precision and concordance of antinuclear antibody measurement. , 1987, Journal of clinical & laboratory immunology.
[78] Frank E. Young,et al. Deoxyribonucleic Acid Antibody: A Method to Detect Its Primary Interaction with Deoxyribonucleic Acid , 1968, Science.
[79] S. Ballou,et al. Anti-native DNA detection by the Crithidia luciliae method: an improved guide to the diagnosis and clinical management of systemic lupus erythematosus. , 1979, Arthritis and rheumatism.
[80] E. Tan. International cooperative activities in standardization of antinuclear antibodies , 1996 .
[81] D. Isenberg,et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. , 1993, Arthritis and rheumatism.
[82] E. Tan,et al. Standardization of the immunofluorescence test for autoantibody to nuclear antigens (ANA): use of reference sera of defined antibody specificity. , 1985, American journal of clinical pathology.
[83] L. Aarden,et al. Prognostic value of anti-dsDNA in SLE. , 1982, Annals of the rheumatic diseases.
[84] Andrea Giordano,et al. Autoantibodies Profile in the Sera of Patients with Sjogren]s Syndrome: The ANA Evaluation—A Homogeneous, Multiplexed System , 2004, Clinical & developmental immunology.
[85] M. Satoh,et al. Systemic lupus erythematosus. Antibodies to DNA, DNA-binding proteins, and histones. , 1994, Rheumatic diseases clinics of North America.
[86] A. Wiik,et al. Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. , 2004, Arthritis and rheumatism.
[87] M. Zeher,et al. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). , 2003, Clinical and experimental rheumatology.
[88] P. Schur,et al. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-Sm and anti-RNP antibody tests. , 2004, Arthritis and rheumatism.
[89] Hiroshi Watanabe,et al. Detection of anti‐nuclear antibodies from patients with systemic rheumatic diseases by elisa using hep‐2 cell nuclei , 1991, Journal of clinical laboratory analysis.
[90] E. Tan,et al. Autoantibodies in the diagnosis of systemicrheumatic diseases , 1995 .
[91] Thomas Skogh,et al. Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy. , 2004, Journal of autoimmunity.
[92] R. Smeenk. Measurement of antibodies to DNA , 1996 .
[93] W. Venrooij. Autoantigens in Connective Tissue Diseases , 1994 .
[94] Allan Wiik,et al. Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis. , 2004, Clinical chemistry.
[95] G. Panayi. Immunology of the Connective Tissue Diseases , 1994, Immunology and Medicine Series.
[96] O. Rekvig,et al. Antinuclear antibody screening in this new millennium: farewell to the microscope? , 2001, Scandinavian journal of rheumatology.
[97] P. Limburg,et al. Prevention of relapses in systemic lupus erythematosus , 1995, The Lancet.
[98] P. Dans. Credibility, Cookbook Medicine, and Common Sense: Guidelines and the College , 1994, Annals of Internal Medicine.
[99] L. Leiva,et al. Antinuclear Antibody (ANA) and ANA Profile Tests in Children with Autoimmune Disorders: A Retrospective Study , 2000, Clinical Rheumatology.
[100] T. E. W. Feltkamp,et al. Standards and reference preparations , 1996 .
[101] T. Medsger,et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.
[102] R. Westhovens,et al. Detection of anti-SSA antibodies by indirect immunofluorescence. , 2004, Clinical chemistry.
[103] R Hal Scofield,et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.
[104] A. Coutinho,et al. Natural autoantibodies. , 1995, Current opinion in immunology.
[105] E. Karlson,et al. Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus. , 2002, The Journal of rheumatology.
[106] K. Moder. Use and interpretation of rheumatologic tests: a guide for clinicians. , 1996, Mayo Clinic proceedings.
[107] Y. Hamashima. Antinuclear antibodies in systemic lupus erythematosus. , 1965, Acta pathologica japonica.
[108] E. Tan,et al. Autoimmunity to the cell cycle-dependent centromere protein p330d/CENP-F in disorders associated with cell proliferation. , 1995, Journal of autoimmunity.
[109] W. V. van Venrooij,et al. The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases. , 1991, Journal of immunological methods.